900M in 5 years would make you happy? Meanwhile drug companies hemeraging cash are valued in the multi billions. What am I missing? Is the paradigm shift from a device being used instead of a drug just not clicking with the investment world or are there big bios/pharmas working to keep this company down? Everything I hear is positive, so why no love? Is there something toxic keeping the institutional investors out. I just don't get it.
News 
Market Data 
Discover 
